Expression of retinoic acid receptor-target genes during retinoic acid therapy for acute promyelocytic leukemia [6]

Leukemia

Volumn 17, Issue 3, 2003, Pages 646-648

  Takitani, K ^a   Koh, M ^a   Zhu, C L ^a   Inoue, A ^a   Kuno, T ^a   Tanoue, H ^a   Miyake, M ^a   Nakagawa, T ^a   Tamai, H ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN EPSILON; CD38 ANTIGEN; COMPLEMENTARY DNA; DAUNORUBICIN; ENOCITABINE; MERCAPTOPURINE; PREDNISOLONE; RETINOIC ACID; RETINOIC ACID RECEPTOR; UNCLASSIFIED DRUG;

ANEMIA; ANTIGEN EXPRESSION; AREA UNDER THE CURVE; BLOOD TRANSFUSION; BONE MARROW BIOPSY; CANCER REGRESSION; CASE REPORT; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DERMATITIS; DNA MICROARRAY; DRUG BLOOD LEVEL; DRUG HALF LIFE; FEMALE; FEVER; GENE TARGETING; GINGIVA BLEEDING; HUMAN; HUMAN CELL; LETTER; LEUKOCYTE COUNT; LEUKOCYTOSIS; MEDICAL EXAMINATION; MOLECULAR MECHANICS; PATIENT TRANSPORT; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTOPENIA; WESTERN BLOTTING;

EID: 0037349074     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402818     Document Type: Letter

References (8)

1. Melnick A, Licht JD. Deconstructing a disease: RAR α, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 1999; 93: 3167-3215.
2. Liu TX, Zhang JW, Tao J, Zhang RB, Zhang QH, Zhao CJ, Tong JH, Lanotte M, Waxman S, Chen SJ, Mao M, Hu GX, Zhu L, Chen Z. Gene expression networks underlying retinoic acid-induced differentiation of acute promyelocytic leukemia cells. Blood 2000; 96: 1496-1504.
3. Takitani K, Tamai H, Morinobu T, Kawamura N, Miyake M, Fujimoto T Mino M. Pharmacokinetics of all-trans retinoic acid in pediatric patients with leukemia. Jpn J Cancer Res 1995; 86: 400-405.
4. Yamanaka R, Barlow C, Lekstrom-Himes J, Castilla LH, Liu PP, Eckhaus M, Decker T, Wynshaw-Boris A, Xanthopoulos KG. Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein E-deficient mice. Proc Natl Acad Sci USA 1997; 94: 13187-13192.
5. Park DJ, Chumakov AM, Vuong PT, Chih DY, Gombart AF, Miller Jr WH, Koeffler HP. CCAAT/enhancer binding protein E is a potential retinoid target gene in acute promyelocytic leukemia treatment. J Clin Invest 1999; 103: 1399-1408.
6. Mehta K, Cheema S. Retinoid-mediated signaling pathways in CD38 antigen expression in myeloid leukemia cells. Leuk Lymphoma 1999; 32: 441-449.
7. Kishimoto H, Hoshino S, Ohori M, Kontani K, Nishina H, Suzawa M, Kato S, Katada T. Molecular mechanism of human CD38 gene expression by retinoic acid. Identification of retinoic acid response element in the first intron. J Biol Chem 1998; 273: 15429-15434.
8. Drach J, Zhao S, Malavasi F, Mehta K. Rapid induction of CD38 antigen on myeloid leukemia cells by all-trans retinoic acid. Biochem Biophys Res Commun. 1993; 195: 545-550.